Menu

Aeglea BioTherapeutics, Inc. AGLE

Full chart Compare
Set alert

Price alert · AGLE

All alert types
12.01 0.00 (+0.00%)

At closeNov 27, 2023, 4:00 PM EST

10.69 Day range 12.34

52-week range unavailable

Revenue & Expenses

Other Income → Expenses: $830.00KIncome Tax Benefit → Expenses: $136.00KExpenses → Selling, General & Admin: $28.53MExpenses → Research & Development: $58.58MGross Profit → Expenses: $2.33MRevenue → Gross Profit: $2.33MNet Loss → Expenses: $83.81MOther Income$830.00KIncome Tax Benefit$136.00KGross Profit$2.33MNet Loss$83.81MExpenses$87.11MSelling, General & Admin$28.53MResearch & Development$58.58MRevenue$2.33M

Latest period ending Dec 31, 2022 · select a line to chart its full history

Annual income statement

AGLE annual income statement
Fiscal yearFY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018
2.33M18.74M003.89M
2.33M18.74M003.89M
2.33M18.74M003.89M
87.11M84.39M81.48M80.33M49.35M
58.58M57.07M59.64M64.60M36.72M
28.53M27.32M21.84M15.73M12.63M
-84.78M-65.65M-81.48M-80.33M-45.46M
-136.00K141.00K000
-83.81M-65.80M-80.89M-78.25M-44.35M
-83.81M-65.80M-80.89M-78.25M-44.35M
-83.81M-65.80M-80.89M-78.25M-44.35M
-83.81M-65.80M-80.89M-78.25M-44.35M
-0.99-1.00-1.52-2.45-2.13
-0.99-1.00-1.52-2.45-2.13
-0.99-1.00-1.52-2.45-2.13
-83.95M-65.66M-80.89M-78.25M-44.35M
-83.95M-65.66M-80.89M-78.25M-44.35M
84.28M65.74M53.37M31.95M20.82M
84.28M65.74M53.37M31.95M20.82M